L. Steinman
Immunology · 2000–2022
A researcher in the Science corpus: 11 papers; trusts 1 researcher and is trusted by 7 researchers here, as inferred from the citation graph.
Subfields
- Immunology — 25 citations into it; #530 of 2,160 by trust here, #865 by citations
Whom L. Steinman trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts L. Steinman overall
Papers from L. Steinman's perspective
Ordered by how strongly the researchers L. Steinman trusts endorse each paper. Same corpus, a different order for every researcher.
- Divergent Pro- and Antiinflammatory Roles for IL-23 and IL-12 in Joint Autoimmune Inflammation (Journal of Experimental Medicine)
- Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells (Nature)
- IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
- A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17 (Nature Immunology)
- Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17–producing T cells (Nature Immunology)
- Requirement of Interleukin 17 Receptor Signaling for Lung Cxc Chemokine and Granulocyte Colony-Stimulating Factor Expression, Neutrophil Recruitment, and Host Defense (Journal of Experimental Medicine)
- A crucial role for interleukin (IL)-1 in the induction of IL-17–producing T cells that mediate autoimmune encephalomyelitis (Journal of Experimental Medicine)
- Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis. (Journal of Clinical Investigation)
- Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor. (Science)
- The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. (Cell)
Their papers
- Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain. (2011) — 1,271 citations
- The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters. (2000) — 1,543 citations
- Autoantigen microarrays for multiplex characterization of autoantibody responses (2002) — 682 citations
- Clonally Expanded B Cells in Multiple Sclerosis Bind EBV EBNA1 and GlialCAM (2022) — 725 citations
- Science Communication to the General Public: Why We Need to Teach Undergraduate and Graduate Students this Skill as Part of Their Formal Scientific Training. (2013) — 411 citations
- A brief history of TH17, the first major revision in the TH1/TH2 hypothesis of T cell–mediated tissue damage (2007) — 1,039 citations
- Statin therapy in autoimmunity: From protein prenylation to immunomodulation (2006) — 679 citations
- Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis (2002) — 1,771 citations
- The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease (2002) — 1,158 citations
- The Influence of the Proinflammatory Cytokine, Osteopontin, on Autoimmune Demyelinating Disease (2001) — 900 citations
- Multiple sclerosis: a two-stage disease (2001) — 648 citations